| Original language | English (US) |
|---|---|
| Pages (from-to) | 995-1003 |
| Number of pages | 9 |
| Journal | Clinical Infectious Diseases |
| Volume | 66 |
| Issue number | 7 |
| DOIs | |
| State | Published - Mar 19 2018 |
Keywords
- Antimicrobial
- Infection prevention
- Infectious diseases
- Resistance
- Stewardship
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical Infectious Diseases, Vol. 66, No. 7, 19.03.2018, p. 995-1003.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Infectious Diseases Physicians
T2 - Leading the Way in Antimicrobial Stewardship
AU - Ostrowsky, Belinda
AU - Banerjee, Ritu
AU - Bonomo, Robert A.
AU - Cosgrove, Sara E.
AU - Davidson, Lisa
AU - Doron, Shira
AU - Gilbert, David N.
AU - Jezek, Amanda
AU - Lynch, John B.
AU - Septimus, Edward J.
AU - Siddiqui, Javeed
AU - Iovine, Nicole M.
N1 - Funding Information: R. A. B. reports compensation from the National Institutes of Health, Antibacterial Resistance Leadership Group; possesses a Veterans Affairs Merit Review Award; and reports compensation for preclinical studies unrelated to this manuscript from Merck, Wockhardt, Allergan, Allereca, and Roche. S. D. reports compensation for speakers bureau participation for Merck and Allergan and compensation for research support from Diatherix. D. N. G. reports compensation for consulting with Biomerieux, Biofire, Merck, and GlaxoSmithKline. S. A. C. reports compensation unrelated to this manuscript for consulting with Novartis and Theravance. E. J. S. reports receiving contributed product from Sage, Molnlycke, and Medline for ABATE and SWAP OUT trials (companies that contribute product have no role in design, conduct, analysis, or publication unrelated to this manuscript). All other authors: no reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: 1Montefiore Medical Center, Albert Einstein Medical Center, Bronx, New York; 2Vanderbilt University Medical Center, Nashville, Tennessee; 3Research and Medical Services Veterans Affairs Medical Center, 4Departments of Medicine, Pharmacology, Molecular Biology and Microbiology, Case Western Reserve University, and 5Cleveland Geriatric Research Education and Clinical Center, Case Western Reserve University–Cleveland Veterans Affairs Medical Center, Center for Antimicrobial Resistance and Epidemiology, Ohio; 6Johns Hopkins University School of Medicine, Baltimore, Maryland; 7Carolinas Health Care System, Charlotte, North Carolina; 8Tufts Medical Center, Boston, Massachusetts; 9Providence-Portland Medical Center and 10Oregon Health Sciences University, Portland; 11Infectious Diseases Society of America, Arlington, Virginia; 12Harborview Medical Center, University of Washington, Seattle; 13HCA Healthcare, Nashville, Tennessee; 14Texas A&M College of Medicine, Houston; 15TeleMed2U, Roseville, California; and 16University of Florida College of Medicine, Gainesville
PY - 2018/3/19
Y1 - 2018/3/19
KW - Antimicrobial
KW - Infection prevention
KW - Infectious diseases
KW - Resistance
KW - Stewardship
UR - http://www.scopus.com/inward/record.url?scp=85044200269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044200269&partnerID=8YFLogxK
U2 - 10.1093/cid/cix1093
DO - 10.1093/cid/cix1093
M3 - Article
AN - SCOPUS:85044200269
SN - 1058-4838
VL - 66
SP - 995
EP - 1003
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 7
ER -